Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Pancreatic Adenocarcinoma”

892 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 892 results

Early research (Phase 1)Active Not RecruitingNCT07021066
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Who this might be right for
Gastric AdenocarcinomaAdvanced Pancreatic Ductal AdenocarcinomaEsophageal Adenocarcinoma+2 more
SystImmune Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableLooking for participantsNCT06524973
What this trial is testing

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
City of Hope Medical Center 136
Early research (Phase 1)WithdrawnNCT04270929
What this trial is testing

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Roger Williams Medical Center
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07445295
What this trial is testing

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 558
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Not applicableStudy completedNCT04467593
What this trial is testing

Safety Study of Whole Body Hyperthermia for Advanced Cancer

Who this might be right for
Advanced CancerPancreatic Cancer Metastatic
ElmediX 16
Testing effectiveness (Phase 2)Looking for participantsNCT06937177
What this trial is testing

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Who this might be right for
Cancer Weight Loss
Endevica Bio 120
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Study completedNCT00366457
What this trial is testing

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 32
Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04348045
What this trial is testing

Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group 307
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07831330
What this trial is testing

Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaAlbumin-bound Paclitaxel (II)Gemcitabine+1 more
The First Affiliated Hospital with Nanjing Medical University 59
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Next Page